A Canadian biotechnology company has revealed a collaboration with the National Football League for a funded clinical trial program. The study will be to determine the relative oral bioavailability and other pharmacokinetic parameters of the non-psychoactive CBD and its metabolites.
(Source: Adobe Stock)
Click here for the full story.
Weekly Update – Top Cannabis News Stories
1 | Top Story: “Twisted” all-in-one vapes hit the market
2 | Sale/leaseback of Peace Naturals Campus facility in Ontario terminated
3 | Canopy Growth reports 7 per cent revenue increase for Q4 2024
Top Cannabis Stocks May 24 to May 30, 2024
1. T.TLRY | 11,455 views | Tilray Brands Inc.
2. T.WEED | 8,478 views | Canopy Growth Corp.
3.T.LABS | 6,923 views | Medipharm Labs Corp.
4. T.CURA| 4,639 views | Curaleaf Holdings Inc.
5. C.OILS | 2,336 views | Nextleaf Solutions Ltd.
6.T.DN | 1,767 views | Delta9 Cannabis Inc.
The material provided in this article is for information only and should not be treated as investment advice. For full disclaimer information, please click here.